Training set augmentation and biology-aware harmonization improve radiomic models for lung cancer prediction in indeterminate nodules

C Claire Huchthausen M Menglin Shi G Gabriel de Sousa J James Larner E Einsley Janowski J Jonathan Colen (James Franck Institute, University of Chicago) K Krishni Wijesooriya

Abstract

Abstract CT radiomics-based machine learning has potential to predict lung cancer in pulmonary nodules (PNs) earlier than standard-of-care methods. Low malignancy rates in early-development PNs and variable image acquisition hinder development of radiomic models for diagnosing these PNs. To address these challenges, we augmented training using later-development PNs and harmonized for acquisition effects. We examine early-development benign and malignant PNs (n = 106) below the sensitivity of standard-of-care diagnosis. Classifiers predicting malignancy performed near chance when trained on ComBat-harmonized radiomic features from only early-development PNs. We then augmented training with later-development benign and malignant PNs (n = 225). We evaluated whether harmonization must incorporate biology that impacts acquisition effects in added training data. To correct variability from four acquisition protocols, we compared: (1) biology-unaware harmonization, (2) harmonizing with a covariate distinguishing early-development, later-development benign, later-development malignant datasets, (3) harmonizing each dataset separately. Models trained using augmentation, but biology-unaware harmonization, failed to improve consistently. Augmented training data harmonized with a covariate (ROC-AUC 0.74 [0.69–0.79]) or separately (ROC-AUC 0.71 [0.66–0.77]) yielded higher test ROC-AUC (Delong, p  ≤ 0.05) and PR-AUC (Wilcoxon, p  ≤ 0.05). In a proof-of-principle methodological study, we demonstrate with a small single-center dataset that combining radiomic features from later-development benign and malignant PNs requires biology-aware harmonization.

Article Details

Volume / Issue Vol. 1, Issue 1
Published June 20, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (7)

C

Claire Huchthausen

M

Menglin Shi

G

Gabriel de Sousa

J

James Larner

E

Einsley Janowski

J

Jonathan Colen

James Franck Institute, University of Chicago

K

Krishni Wijesooriya